Abstract:Background: Gap junctions, which serve as intercellular channels that allow the passage of ions and other small molecules between neighboring cells, play an important role in vital functions, including the regulation of cell growth, differentiation, and development. Statins, the 3-hydroxy-3-methylglutaryl-coenzymeA (HMG-CoA) reductase inhibitors, have been shown to inhibit the migration and proliferation of smooth muscle cells (SMCs) leading to an antiproliferative effect. Recent studies have shown that statins can reduce gap junction protein connexin43 (Cx43) expression both in vivo and in vitro. However, little work has been done on the effects of statins on gap junctional intercellular communication (GJIC). We hypothesized in this study that lovastatin inhibits vascular smooth muscle cells (VSMCs) migration through the inhibition of the GJIC. Methods: Rat aortic SMCs (RASMCs) were exposed to lovastatin. Vascular smooth muscle cells migration was then assessed with a Transwell migration assay. Gap junctional intercellular communication was determined by using fluorescence recovery after photobleaching (FRAP) analysis, which was performed with a laser-scanning confocal microscope. Results: The migration of the cultured RASMCs were detected by Trans. well system. Cell migration was dose-dependently inhibited with lovastatin. Compared with that in the control (110 +/- 26), the number of migrated SMCs was significantly reduced to 72 +/- 24 (P < .05), 62 +/- 18 (P < .01), and 58 +/- 19 (P < .01) at the concentration of 0.4, 2, and 10 umol/L, per field. The rate of fluorescence recovery (R) at 5 minutes after photobleaching was adopted as the functional index of GJIC. The R- value of cells exposed to lovastatin 10 umol/L for 48 hours was 24.38% +/- 4.84%, whereas the cells in the control group had an R- value of 36.11% +/- 10.53%, demonstrating that the GJIC of RASMCs was significantly inhibited by lovastatin (P < .01). Smaller concentrations of lovastatin 0.08 umol/L did not change gap junction coupling (P > .05). Conclusions: These results suggest that lovastatin inhibits migration in a dose-dependent manner by attenuating JIC. Suppression of gap junction function could add another explanation of statin-induced antiproliferative effect.

Inhibition of Triggered Activities in Pulmonary Veins: Do Statins Have a Direct and Clinically Relevant Antiarrhythmic Effect?

Fluvastatin reduces pulmonary vein spontaneous activity through nitric oxide pathway

Lovastatin inhibits gap junctional communication in cultured aortic smooth muscle cells.

Statins and Prevention of Stroke in Patients with Non-Alcoholic Fatty Liver Disease

Statins and Prevention of Atrial Fibrillation in Patients with Heart Failure.

Pleiotropic use of Statins as non-lipid-lowering drugs

Statins Inhibit Pulmonary Artery Smooth Muscle Cell Proliferation by Upregulation of HO-1 and P21 WAF1

Effect of Statins on Prevention and Treatment for Chronic Obstructive Plumonary Diseases

Cyclic nucleotides and mitogen-activated protein kinases: regulation of simvastatin in platelet activation

Attenuation by Statins of Membrane Raft-Redox Signaling in Coronary Arterial Endothelium.

Value of Statin in Percutaneous Coronary Intervention

[Simvastatin Inhibits Hypertension-Induced Cardiac Hypertrophy in Rats Through Activation of Heme Oxygenase-1/Carbon Monoxide Pathway].

Anti-inflammatory Effect of Statins in Pulmonary Disease

Inhibition of serotonin-induced mitogenesis, migration, and ERK MAPK nuclear translocation in vascular smooth muscle cells by atorvastatin

Pleiotropic effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors: candidate mechanisms for anti-lipid deposition in blood vessels

Potential Benefits of Statins in Chronic Obstructive Pulmonary Disease

Overview of Therapeutic Effects of Statins on Inflammatory Diseases Through Regulating Adhesive Molecules

Effect of Statins on Platelet Activation and Function: From Molecular Pathways to Clinical Effects

Short-Term and Long-Term Fluvastatin Inhibit Effects of Thrombospondin-1 on Human Vascular Smooth Muscle Cells

Therapeutic Effects of Lipid Lowering Medications on Myocardial Blood Flow, Inflammation, and Sympathetic Nerve Activity Using Nuclear Techniques

Effect of Statin Therapy on Arrhythmias